发明授权
EP1796688B1 PANCREATIC CANCER TREATMENT USING NA+/K+ ATPASE INHIBITORS
有权
治疗胰腺癌用Na + / K + -ATP酶抑制剂的
- 专利标题： PANCREATIC CANCER TREATMENT USING NA+/K+ ATPASE INHIBITORS
- 专利标题（中）： 治疗胰腺癌用Na + / K + -ATP酶抑制剂的
-
申请号： EP05794315.1申请日： 2005-09-02
-
公开(公告)号： EP1796688B1公开(公告)日： 2011-05-18
- 发明人: KHODADOUST, Mehran - c/o BT Intern. Ltd. , SHARMA, Ajay
- 申请人： Bionaut Pharmaceuticals Inc
- 申请人地址： 16 Rustic Road Stoneham, MA 02180 US
- 专利权人： Bionaut Pharmaceuticals Inc
- 当前专利权人： Bionaut Pharmaceuticals Inc
- 当前专利权人地址： 16 Rustic Road Stoneham, MA 02180 US
- 代理机构： Tomkinson, Alexandra
- 优先权： US606684P 20040902
- 国际公布： WO2006028969 20060316
- 主分类号： A61K31/704
- IPC分类号： A61K31/704 ; A61P35/00
摘要：
The reagent, pharmaceutical formulation, kit, and methods of the invention provides a new approach for treating pancreatic cancers. The invention provides the use of Na+/K+-ATPase inhibitors, such as cardiac glycosides (e.g. ouabain and proscillaridin, etc.), either alone or in combination with other standard therapeutic agents (chemo- or radio-therapies, etc.) for treating pancreatic cancers.
公开/授权文献
- EP1796688A1 PANCREATIC CANCER TREATMENT USING NA+/K+ ATPASE INHIBITORS 公开/授权日：2007-06-20
信息查询
IPC分类:
